Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast ...
A T-cell therapy developed by Orca Bio, a private biotech company, significantly reduced the risk of a debilitating immune ...
Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced ...
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
An international group of researchers has identified an important mechanism that enables stem cells to evade immune rejection ...
JERUSALEM (AP) — An American biochemist whose research has helped scientists make inroads into treating coronavirus and HIV ...
Nck modulator reduced evidence of inflammation in an animal model of dermal irritation. Compelling preclinical data support continued development of Nck modulators in atopic derma ...
Sex Delta by Cell Type. In men with Alzheimer’s (top left), B cells (red boxes) were fewer (blue), while NK cells (blue boxes ...
High-parameter flow cytometry of peripheral blood mononuclear cells enabled physicians to treat recalcitrant erythroderma in ...
2 Tianjin Clinical Research Center for Rheumatic and Immune Diseases, Tianjin ... is to profile the transcriptional landscapes of affected tissues and peripheral blood mononuclear cells (PBMCs) at the ...